BIOTON S.A. (FRA:7U5)

Germany flag Germany · Delayed Price · Currency is EUR
0.926
-0.004 (-0.43%)
Last updated: Dec 4, 2025, 8:07 AM CET
28.97%
Market Cap 81.18M
Revenue (ttm) 69.32M
Net Income (ttm) -661.58K
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.926
Previous Close 0.930
Day's Range 0.926 - 0.926
52-Week Range 0.639 - 1.150
Beta n/a
RSI 39.75
Earnings Date Feb 6, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 364
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 7U5
Full Company Profile

Financial Performance

Financial numbers in PLN Financial Statements

News

There is no news available yet.